ARCHIVES

Tyrosine Kinase Inhibitor Encoraging For NSCLC

This article is from The Cancer Letter archive.

Vol. 24 No. 7 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

New Treatment For CML Could Be Model for Molecular Target-Based Therapeutics

December 10, 1999

In Brief: extramural Affairs Director Diggs to Leave NIH; Bonadonna, Fisher Share Bristol-Meyer Award

April 2, 1993

Sam Broder Receives Arthur Flemming Award

June 1, 1984

Two Groups Form to Mark Cancer Act’s 25th Anniversary

May 31, 1996

FDA Ponders Standards For “Retrospective Prospective” Studies

January 30, 2009

Majority Of Americans Support Cigarette Tax Increase, Survey Finds

May 28, 1993